Skip to main content
. 2021 Jan 27;31(1):12–16. doi: 10.1093/eurpub/ckaa226

Table 2.

Estimated regression coefficient of factors not included in the final model, if the factor was added to the final multiple linear regression model for prediction of COVID-19 mortality

Term Coefficient (standard error) 95% confident interval P-value
Proportion of people aged 15–64 −0.0019 (0.0107) (−0.0231, 0.0194) 0.863
Population in 2018 (100 million of people) 0.0002 (0.0242) (−0.0478, 0.0481) 0.995
Proportion of females in population (%) 0.0006 (0.0199) (−0.0388, 0.0400) 0.976
Life expectancy at birth (years) −0.0040 (0.0122) (−0.0282, 0.0201) 0.741
Neonatal mortality rate (%) 0.0108 (0.0075) (−0.0040, 0.0256) 0.150
Mortality from CVD, cancer, diabetes or CRD between ages 30 and 70 (%) −0.0071 (0.0109) (−0.0286, 0.0144) 0.514
Cause of death by injury (% of total) 0.0017 (0.0128) (−0.0238, 0.0271) 0.898
Hypertension prevalence (%) 0.0037 (0.0061) (−0.0083, 0.0157) 0.539
Diabetes prevalence (% of population aged 20–79) 0.0013 (0.0130) (−0.0245, 0.0271) 0.921
Number of physicians (per 1000 people) −0.0518 (0.0652) (−0.1809, 0.0773) 0.428
Immunization, measles (% of children aged 12–23 months) −0.0056 (0.0035) (−0.0126, 0.0013) 0.113
BCG immunization strategy (binary) −0.3258 (0.2278) (−0.7768, 0.1251) 0.155
Number of days since the first case of COVID-19 0.0000 (0.0022) (−0.0045, 0.0044) 0.992

BCG, Bacillus Calmette–Guérin; CRD, chronic respiratory disease; CVD, cardiovascular diseases.